The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes
Open accessAbstract
Cell-based antitumor immunity is driven by CD8+ cytotoxic T cells bearing TCR that recognize specific tumor-associated peptides bound to class I MHC molecules. Of several cellular proteins involved in T cell:target-cell interaction, the TCR determines specificity of binding; however, the relative amount of its contribution to cellular avidity remains unknown. To study the relationship between TCR affinity and cellular avidity, with the intent of identifying optimal TCR for gene therapy, we derived 24 MART-1:27-35 (MART-1) melanoma Ag-reactive tumor-infiltrating lymphocyte (TIL) clones from the tumors of five patients. These MART-1-reactive clones displayed a wide variety of cellular avidities. α and β TCR genes were isolated from these clones, and TCR RNA was electroporated into the same non-MART-1-reactive allogeneic donor PBMC and TIL. TCR recipient cells gained the ability to recognize both MART-1 peptide and MART-1-expressing tumors in vitro, with avidities that closely corresponded to the original TCR clones (p = 0.018–0.0003). Clone DMF5, from a TIL infusion that mediated tumor regression clinically, showed the highest avidity against MART-1 expressing tumors in vitro, both endogenously in the TIL clone, and after RNA electroporation into donor T cells. Thus, we demonstrated that the TCR appeared to be the core determinant of MART-1 Ag-specific cellular avidity in these activated T cells and that nonreactive PBMC or TIL could be made tumor-reactive with a specific and predetermined avidity. We propose that inducing expression of this highly avid TCR in patient PBMC has the potential to induce tumor regression, as an “off-the-shelf” reagent for allogeneic melanoma patient gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
T-cell antigen receptor genes and T-cell recognition
Davis, M. M., & Bjorkman, P. J. (1988) · Nature · doi:10.1038/334395a0 · Cited by 3,202
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Self-citationA New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
Rosenberg, S. A., Spiess, P., & Lafreniere, R. (1986) · Science · doi:10.1126/science.3489291 · Cited by 1,880
Self-citationDudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Self-citationProgress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
Self-citationGattinoni, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24480 · Cited by 958
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6458 · Cited by 914
Self-citationKawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., & Rosenberg, S. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.347 · Cited by 862
Self-citationAdoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Self-citationJourney through the thymus: stromal guides for T-cell development and selection
Takahama, Y. (2006) · Nature Reviews Immunology · doi:10.1038/nri1781 · Cited by 728
Schneider, U., Schwenk, H., & Bornkamm, G. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190505 · Cited by 700
HUMAN T CELL RESPONSES AGAINST MELANOMA
Boon, T., Coulie, P. G., Eynde, B. J. V. D., & Bruggen, P. V. D. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090733 · Cited by 651
Alexander-Miller, M. A., Leggatt, G. R., & Berzofsky, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4102 · Cited by 501
A Kinetic Basis For T Cell Receptor Repertoire Selection during an Immune Response
Savage, P. A., Boniface, J. J., & Davis, M. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80048-5 · Cited by 497
Cohen, C. J., Zhao, Y., Zheng, Z., Rosenberg, S. A., & Morgan, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1450 · Cited by 469
Self-citationRobbins, P. F., Dudley, M. E., Wunderlich, J., El-Gamil, M., Li, Y. F., Zhou, J., Huang, J., Powell, D. J., & Rosenberg, S. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7125 · Cited by 463
Self-citationHigh Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy
Zeh, H. J., Perry-Lalley, D., Dudley, M. E., Rosenberg, S. A., & Yang, J. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.989 · Cited by 376
Self-citationQuantitative Analysis of the Contribution of TCR/pepMHC Affinity and CD8 to T Cell Activation
Holler, P. D., & Kranz, D. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00019-0 · Cited by 347
Agonist/endogenous peptide–MHC heterodimers drive T cell activation and sensitivity
Krogsgaard, M., Li, Q.-J., Sumen, C., Huppa, J. B., Huse, M., & Davis, M. M. (2005) · Nature · doi:10.1038/nature03391 · Cited by 346
Zhou, J., Shen, X., Huang, J., Hodes, R. J., Rosenberg, S. A., & Robbins, P. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.7046 · Cited by 335
Self-citationKalergis, A. M., Boucheron, N., Doucey, M.-A., Palmieri, E., Goyarts, E. C., Vegh, Z., Luescher, I. F., & Nathenson, S. G. (2001) · Nature Immunology · doi:10.1038/85286 · Cited by 322
T Cell Receptor-MHC Class I Peptide Interactions: Affinity, Kinetics, and Specificity
Corr, M., Slanetz, A. E., Boyd, L. F., Jelonek, M. T., Khilko, S., al-Ramadi, B. K., Kim, Y. S., Maher, S. E., Bothwell, A. L. M., & Margulies, D. H. (1994) · Science · doi:10.1126/science.8052850 · Cited by 301
T Cell Receptor-MHC Class I Peptide Interactions: Affinity, Kinetics, and Specificity
Fisher, R. J., & Fivash, M. (1995) · Science · doi:10.1126/science.7701331 · Cited by 296
Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer
Ohashi, P. S., Mak, T. W., Van den Elsen, P., Yanagi, Y., Yoshikai, Y., Calman, A. F., Terhorst, C., Stobo, J. D., & Weiss, A. (1985) · Nature · doi:10.1038/316606a0 · Cited by 296
Krogsgaard, M., & Davis, M. M. (2005) · Nature Immunology · doi:10.1038/ni1173 · Cited by 280
Krogsgaard, M., Prado, N., Adams, E. J., He, X.-L., Chow, D.-C., Wilson, D. B., Garcia, K. C., & Davis, M. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00474-x · Cited by 247
Hughes, M. S., Yu, Y. Y. L., Dudley, M. E., Zheng, Z., Robbins, P. F., Li, Y., Wunderlich, J., Hawley, R. G., Moayeri, M., Rosenberg, S. A., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.457 · Cited by 231
Self-citationMorgan, R. A., Dudley, M. E., Yu, Y. Y. L., Zheng, Z., Robbins, P. F., Theoret, M. R., Wunderlich, J. R., Hughes, M. S., Restifo, N. P., & Rosenberg, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3287 · Cited by 228
Self-citationIncreased TCR Avidity after T Cell Activation A Mechanism for Sensing Low-Density Antigen
Fahmy, T. (2001) · Immunity · doi:10.1016/s1074-7613(09)00099-5 · Cited by 218
Zhao, Y., Zheng, Z., Robbins, P. F., Khong, H. T., Rosenberg, S. A., & Morgan, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4415 · Cited by 191
Self-citationRowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Groom‐Carter, D., Lee, S., Burrows, S. R., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250536 · Cited by 191
Wooldridge, L., van den Berg, H. A., Glick, M., Gostick, E., Laugel, B., Hutchinson, S. L., Milicic, A., Brenchley, J. M., Douek, D. C., Price, D. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500555200 · Cited by 167
TCR affinity and negative regulation limit autoimmunity
Gronski, M. A., Boulter, J. M., Moskophidis, D., Nguyen, L. T., Holmberg, K., Elford, A. R., Deenick, E. K., Kim, H. O., Penninger, J. M., Odermatt, B., et al. (2004) · Nature Medicine · doi:10.1038/nm1114 · Cited by 151
Cohen, C. J., Zheng, Z., Bray, R. B., Zhao, Y., Sherman, L. A., Rosenberg, S. A., & Morgan, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5799 · Cited by 138
Self-citational-Ramadi, B. K., Jelonek, M. T., Boyd, L. F., Margulies, D. H., & Bothwell, A. L. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.662 · Cited by 120
Hernández, J., Lee, P. P., Davis, M. M., & Sherman, L. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.596 · Cited by 110
Holler, P. D., Lim, A. R., Cho, B. K., Rund, L. A., & Kranz, D. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1043 · Cited by 103
Speiser, D. E., Kyburz, D., Stübi, U., Hengartner, H., & Zinkernagel, R. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.972 · Cited by 102
Hutchinson, S., Wooldridge, L., Tafuro, S., Laugel, B., Glick, M., Boulter, J. M., Jakobsen, B. K., Price, D. A., & Sewell, A. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300633200 · Cited by 90
Valmori, D., Dutoit, V., Líénard, D., Lejeune, F. J., Speiser, D. E., Rimoldi, D., Cerundolo, V., Dietrich, P., Cerottini, J., & Romero, P. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.533 · Cited by 89
High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining
Choi, E. M.-L., Chen, J., Wooldridge, L., Salio, M., Lissina, A., Lissin, N. M., Hermans, I. F., Silk, J. D., Mirza, F., Palmowski, M. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5116 · Cited by 83
Bullock, T. N. J., Mullins, D. W., Colella, T. A., & Engelhard, V. H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5824 · Cited by 77
Lyman, M. A., Aung, S., Biggs, J., & Sherman, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6558 · Cited by 76
Optimal Colocalization of TCR and CD8 as a Novel Mechanism for the Control of Functional Avidity
Cawthon, A. G., & Alexander‐Miller, M. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3492 · Cited by 76
Alexander‐Miller, M. A. (2004) · Immunologic Research · doi:10.1385/ir:31:1:13 · Cited by 74
Targeting self-antigens through allogeneic TCR gene transfer
de Witte, M. A., Coccoris, M., Wolkers, M. C., van den Boom, M. D., Mesman, E. M., Song, J., van der Valk, M., Haanen, J. B. A. G., & Schumacher, T. N. (2006) · Blood · doi:10.1182/blood-2005-08-009357 · Cited by 70
CD8-Independent Tumor Cell Recognition Is a Property of the T Cell Receptor and Not the T Cell
Roszkowski, J. J., Yu, D. C., Rubinstein, M. P., McKee, M. D., Cole, D. J., & Nishimura, M. I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2582 · Cited by 63
Echchakir, H., Dorothée, G., Vergnon, I., Menez, J., Chouaïb, S., & Mami‐Chouaib, F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142308199 · Cited by 59
Wooldridge, L., Hutchinson, S., Choi, E. M.-L., Lissina, A., Jones, E., Mirza, F., Dunbar, P. R., Price, D. A., Cerundolo, V., & Sewell, A. K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6650 · Cited by 56
The Fate of Low Affinity Tumor-Specific CD8+ T Cells in Tumor-Bearing Mice
Lyman, M. A., Nugent, C., Marquardt, K., Biggs, J., Pamer, E. G., & Sherman, L. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2563 · Cited by 54
Functionally Impaired HIV-Specific CD8 T Cells Show High Affinity TCR-Ligand Interactions
Ueno, T., Tomiyama, H., Fujiwara, M., Oka, S., & Takiguchi, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5451 · Cited by 51
Palermo, B., Campanelli, R., Mantovani, S., Lantelme, E., Manganoni, A. M., Carella, G., Prada, G. D., della Cuna, G. R., Romagné, F., Gauthier, L., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200102)31:2<412::aid-immu412>3.0.co;2-4 · Cited by 46
Cited by
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A., & Dudley, M. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2355 · Cited by 1,659
Self-citationJohnson, L. A., Morgan, R. A., Dudley, M. E., Cassard, L., Yang, J. C., Hughes, M. S., Kammula, U. S., Royal, R. E., Sherry, R. M., Wunderlich, J. R., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211714 · Cited by 1,418
Self-citationCancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Morgan, R. A., Chinnasamy, N., Abate-Daga, D., Gros, A., Robbins, P. F., Zheng, Z., Dudley, M. E., Feldman, S. A., Yang, J. C., Sherry, R. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182829903 · Cited by 1,148
Self-citationIdentification of essential genes for cancer immunotherapy
Patel, S. J., Sanjana, N. E., Kishton, R. J., Eidizadeh, A., Vodnala, S. K., Cam, M., Gartner, J. J., Jia, L., Steinberg, S. M., Yamamoto, T. N., et al. (2017) · Nature · doi:10.1038/nature23477 · Cited by 870
Self-citationBassani-Sternberg, M., Bräunlein, E., Klar, R., Engleitner, T., Sinitcyn, P., Audehm, S., Straub, M., Weber, J., Slotta-Huspenina, J., Specht, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms13404 · Cited by 693
Metadata
- Authors
- Johnson, L. A., Heemskerk, B., Powell, D. J., Cohen, C. J., Morgan, R. A., Dudley, M. E., Robbins, P. F., & Rosenberg, S. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11-01
- Volume
- 177
- Issue
- 9
- Pages
- 6548-6559
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2121315503
- Cited by
- 343
- References
- 53
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.